Zebra Capital Management’s Integra LifeSciences IART Stock Holding History

Zebra Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-24,560	Closed	-$832K	–	256
2015 Q4	$832K	Buy	24,560 +1,552	+7%	+$48.5K	0.46%	79
2015 Q3	$685K	Sell	23,008 -4,860	-17%	-$152K	0.42%	96
2015 Q2	$767K	Sell	27,868 -3,988	-13%	-$106K	0.45%	92
2015 Q1	$803K	Buy	+31,856	New	+$753K	0.41%	121

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Zebra Capital Management's IART Position: Q1 2016 in Review

Zebra Capital Management sold out of Integra LifeSciences (IART) in Q1 2016, closing a stake of 24,560 shares — an estimated $832K sold.

Zebra Capital Management first reported a position in IART in Q1 2015 and held it in 4 quarters. The position peaked at $832K in Q4 2015. 194 funds tracked by Wall St. Rank hold IART as of Q1 2016.

Zebra Capital Management reported no remaining Integra LifeSciences position as of Q1 2016 after selling out during the quarter.
Zebra Capital Management sold 24,560 Integra LifeSciences shares in Q1 2016, an estimated $832K.
Zebra Capital Management first reported a position in Integra LifeSciences in Q1 2015 and held it in 4 quarters.
Zebra Capital Management's Integra LifeSciences position peaked at $832K in Q4 2015.
194 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2016.

Based on Zebra Capital Management's 13F filing for Q1 2016, filed 12 May 2016.